|
|
|
Volumn 9, Issue 7, 1996, Pages 127-133
|
|
Outcomes assessment in osteoporosis: strategies for improvement.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
ESTROGEN;
FLUORIDE SODIUM;
PROGESTERONE;
ARTICLE;
COST OF ILLNESS;
ESTROGEN THERAPY;
EXERCISE;
FEMALE;
HEALTH INSURANCE;
HUMAN;
INTRANASAL DRUG ADMINISTRATION;
OSTEOPOROSIS;
OUTCOME ASSESSMENT;
PATHOPHYSIOLOGY;
QUALITY OF LIFE;
STANDARD;
ADMINISTRATION, INTRANASAL;
ALENDRONATE;
CALCITONIN;
COST OF ILLNESS;
DIPHOSPHONATES;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
EXERCISE;
FEMALE;
HUMANS;
MANAGED CARE PROGRAMS;
OSTEOPOROSIS;
OUTCOME ASSESSMENT (HEALTH CARE);
PROGESTERONE;
QUALITY OF LIFE;
SODIUM FLUORIDE;
|
|
EID: 0030191381
PISSN: 08964831
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
